Status:

COMPLETED

Acute Application of Antibiotic Powder in Open Fracture Wounds

Lead Sponsor:

University of Colorado, Denver

Collaborating Sponsors:

Denver Health and Hospital Authority

Conditions:

Fractures, Open

Wounds and Injuries--Infections

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to help determine the best treatment for severe injures like open fracture wounds. Some broken bone injuries can be more likely to get an infection. It is mostly due to t...

Detailed Description

The investigators aim to investigate the effectiveness of preoperative intrawound antibiotic powder in preventing infection and reducing bacterial burden after open fracture. The investigators hypoth...

Eligibility Criteria

Inclusion

  • Subject or proxy willing and able to provide written informed consent.
  • Age between 18 years and 80 years (inclusive), with an upper or lower extremity Gustilo Type II, IIIA, or IIIB open fractures requiring debridement and internal fixation.
  • Open extremity fractures
  • Time from injury to study intervention 24 hours or less

Exclusion

  • Individuals under the age of 18 years or over 80 years
  • Type I or IIIC open fractures
  • Over 24 hours from time of injury
  • Subjects who have received acute operative care of the open fracture at an outside facility prior to presenting at the Emergency Department.
  • Open fractures distal to the wrist and midfoot
  • History of chronic infection in the extremity involved.
  • Subjects who are currently pregnant
  • Subjects who are Prisoners
  • Subjects with a known allergy to vancomycin or tobramycin
  • Subjects with a condition or social circumstances that would reduce adherence and follow-up.
  • Subjects Participating in other clinical research involving investigational antimicrobial products within 30 days of randomization.

Key Trial Info

Start Date :

June 14 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04872400

Start Date

June 14 2021

End Date

September 30 2023

Last Update

February 5 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Colorado Anschutz

Aurora, Colorado, United States, 80045

2

Denver Health and Hospital Authority

Denver, Colorado, United States, 80204